Fig. 2From: Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened populationSimulated Kaplan–Meier curves for prostate-cancer-specific survival based on applying MRI adjustments to a previously described population cohort dataset of 10,139 men with long-term survival outcomes [24] A. European Association of Urology (EAU) 3-tier risk model B. American Urological Association (AUA) 4-tier risk model C. UK National Institute for Health and Care Excellence – Cambridge Prognostic Group 5-tier (CPG) prognostic modelBack to article page